Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the male ...

Kaminski and his colleagues were pioneers in applying high-throughput, genome-scale transcript profiling to advanced lung ...

Sitting in my doctor's examination room, I was surprised when she told me, "Genetics don't really matter for chronic disease.

Pulmonary fibrosis (PF) is a progressive interstitial lung disease (ILD ... A tyrosine kinase inhibitor that targets profibrotic pathways (VEGFR, FGFR, and PDGFR). Immunomodulators (for non ...

and hemodynamic changes associated with pulmonary hypertension. Also, the investigators identified that pathways involving inflammation and oxidative stress may play significant roles in disease ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...

AbbVie's Emrelis is the first non-small cell lung cancer therapy approved for patients with high c-Met expression levels who ...

The two-year partnership aligns with the company’s mission to transform healthcare and improve patient outcomes through ...

Following recent approvals in the EU, US and China, the Singapore approval is based on two replicate phase 3 studies that showed Dupixent achieved significant reduction in exacerbations, and also ...

Researchers at Baylor College of Medicine and collaborating institutions have uncovered a key molecular player that is ...